Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05
Published January 15, 2025 · Recall initiated: December 16, 2024
Summary
FDA records drug Class II recall D-0182-2025, published January 15, 2025 and initiated December 16, 2024. Recalling firm: FDC Limited; Status: Ongoing; Reported quantity: 136,181 bottles; Lot: Lot: 083L111, Exp. 11/30/2025; 084A032, Exp. 12/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
What to do
Voluntary: Firm initiated · Letter
Get an email if CIPROFLOXACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CIPROFLOXACIN
- Manufacturer
- FDC Limited
- Distributor
- Nationwide
- UPC
- 0369315308028
- Lot
- Lot: 083L111, Exp. 11/30/2025; 084A032, Exp. 12/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDACiprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. BoxNovember 11, 2026
- FDACiprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O.November 11, 2026
- FDACiprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: LeadingMarch 26, 2025
- FDAClonazepam Orally Disintegrating Tablets, USP, 1 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cardsJanuary 15, 2025
- FDAMethadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: HikmaJanuary 15, 2025
- FDACiprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5August 7, 2024
Questions about this recall
Was Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05 recalled?
Yes. FDA published recall D-0182-2025 on January 15, 2025. Reported hazard: Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CIPROFLOXACIN. UPC: 0369315308028.